Join
Live feed
·
INSIDERFilingvia Quantisnow
Zenas BioPharma Inc. logo

Director Enright Patrick G converted options into 2,061,934 shares and bought $7,480,000 worth of shares (440,000 units at $17.00) (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ZBIO· Zenas BioPharma Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ZBIO (Zenas BioPharma Inc.) and more on Quantisnow.

Director Enright Patrick G converted options into 2,061,934 shares and bought $7,480,000 worth of shares (440,000 units at $17.00) (SEC Form 4) | Quantisnow